Results 191 to 200 of about 32,498 (309)

A lack of open data standards for large infrastructure projects hampers social-ecological research in the Brazilian Amazon. [PDF]

PeerJ
Hyde JL, Swanson C, Bohlman SA, Athayde S, Bruna EM, Valle DR.   +5 more
europepmc   +1 more source

Screening of SERT and p11 mRNA Levels in Airline Pilots: A Translational Approach. [PDF]

Front Psychiatry, 2022
Becerril-Villanueva E, Olvera-Alvarez MI, Alvarez-Herrera S, Maldonado-García JL, López-Torres A, Ramírez-Marroquín OA, González-Ruiz O, Nogueira-Fernández JM, Mendoza-Contreras JM, Sánchez-García HO, José-Alfallo JA, Valencia Baños A, Torres-Serrano AB, Jiménez-Genchi J, Mendieta-Cabrera D, Pérez-Sánchez G, Pavón L.   +16 more
europepmc   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source

Effects of a worksite labor gymnastics program on novice and experienced workers. [PDF]

Rev Bras Med Trab
da Silva JNM, Bispo LGM, Silva CMS, Leite WKDS, Vieira EMA, Lima TDFM.   +5 more
europepmc   +1 more source

[Legal framework for home delivery of medication]. [PDF]

Actual Pharm, 2022
Mrozovski JM.
europepmc   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Angiogenesis Dynamics: A Computational Model of Intravascular Flow Within a Structural Adaptive Vascular Network. [PDF]

Biomedicines
Nivlouei SJ, Guerra A, Belinha J, Mangir N, MacNeil S, Salgado C, Monteiro FJ, Natal Jorge R.   +7 more
europepmc   +1 more source

Aquaporin‐4 in Narcolepsy Type 1: Investigation of Perivascular Fluid Movement in Sleep Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Narcolepsy type 1 (NT1) is caused by the loss of hypocretin‐1 leading to excessive daytime sleepiness and cataplexy. Additionally, disrupted nighttime sleep has become an increasingly recognized feature of NT1. As the glymphatic fluid movement has been linked to sleep architecture, we investigated cerebrospinal fluid (CSF) Aquaporin‐4 (AQP4 ...
Jonas Ranke, Petra Steinacker, Steffen Halbgebauer, Patrick Oeckl, Geert Mayer, Markus Otto   +5 more
wiley   +1 more source

Pyrolysis converts urban pruning waste into biochar with soil and climate benefits. [PDF]

Sci Rep
de Jesus Paula R, de Almeida Pereira V, Latorre FL, Oliveira de Souza Nogueira C, de Almeida IA, Freitas E Silva PA, Ferreira OE, de Lima RP, da Silva Bezerra AC, Machado ART.   +9 more
europepmc   +1 more source

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub, Michele K. York, Roseanne Dobkin, Anuprita R. Nair, Ryan Kurth, David‐Erick Lafontant, Chelsea Caspell‐Garcia, Roy N. Alcalay, Ethan G. Brown, Lana M. Chahine, Christopher Coffey, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kenneth Marek, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, Andrew Siderowf, Cristina Simonet, Tanya Simuni, Caroline M. Tanner, Thomas F. Tropea, Aleksandar Videnovic, The Parkinson's Progression Markers Initiative   +24 more
wiley   +1 more source